US 9512118
Crystal of fused heterocyclic compound
granted A61PA61P25/18A61P43/00
Quick answer
US patent 9512118 (Crystal of fused heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P25/18, A61P43/00